Kevin Marsh/Malar J

Identifying prognostic factors of severe metabolic acidosis and uraemia in African children with severe falciparum malaria: a secondary analysis of a randomized trial.Mzumara G Leopold S Marsh K Dondorp A Ohuma EO Mukaka M
Malar J, (2021). 20:282

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.Ochola-Oyier LI Okombo J Wagatua N Ochieng J Tetteh KK Fegan G Bejon P Marsh K
Malar J, (2016). 15:261

Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast.Kangoye DT Noor A Midega J Mwongeli J Mkabili D Mogeni P Kerubo C Akoo P Mwangangi J Drakeley C Marsh K Bejon P Njuguna P
Malar J, (2016). 15:213

Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.Shelton JM Corran P Risley P Silva N Hubbart C Jeffreys A Rowlands K Craik R Cornelius V Hensmann M Molloy S Sepulveda N Clark TG Band G Clarke GM Spencer CC Kerasidou A Campino S Auburn S Tall A Ly AB Mercereau-Puijalon O Sakuntabhai A Djimde A Maiga B Toure O Doumbo OK Dolo A Troye-Blomberg M Mangano VD Verra F Modiano D Bougouma E Sirima SB Ibrahim M Hussain A Eid N Elzein A Mohammed H Elhassan A Elhassan I Williams TN Ndila C Macharia A Marsh K Manjurano A Reyburn H Lemnge M Ishengoma D Carter R Karunaweera N Fernando D Dewasurendra R Drakeley CJ Riley EM Kwiatkowski DP Rockett KA Malaria GENConsortium
Malar J, (2015). 14:333

Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya.Hodgson SH Juma E Salim A Magiri C Njenga D Molyneux S Njuguna P Awuondo K Lowe B Billingsley PF Cole AO Ogwang C Osier F Chilengi R Hoffman SL Draper SJ Ogutu B Marsh K
Malar J, (2015). 14:182

Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies.Hodgson SH Douglas AD Edwards NJ Kimani D Elias SC Chang M Daza G Seilie AM Magiri C Muia A Juma EA Cole AO Rampling TW Anagnostou NA Gilbert SC Hoffman SL Draper SJ Bejon P Ogutu B Marsh K Hill AV Murphy SC
Malar J, (2015). 14:33

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.Vekemans J Marsh K Greenwood B Leach A Kabore W Soulanoudjingar S Asante KP Ansong D Evans J Sacarlal J Bejon P Kamthunzi P Salim N Njuguna P Hamel MJ Otieno W Gesase S Schellenberg D Clinical Trials Partnership Committee
Malar J, (2011). 10:221

Congenital and neonatal malaria in a rural Kenyan district hospital: an eight-year analysis.Mwaniki MK Talbert AW Mturi FN Berkley JA Kager P Marsh K Newton CR
Malar J, (2010). 9:313

What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.Kinyanjui SM Bejon P Osier FH Bull PC Marsh K
Malar J, (2009). 8:242

Characterization of the repertoire diversity of the Plasmodium falciparum stevor multigene family in laboratory and field isolates.Blythe JE Niang M Marsh K Holder AA Langhorne J Preiser PR
Malar J, (2009). 8:140

Chloroquine resistance before and after its withdrawal in Kenya.Mwai L Ochong E Abdirahman A Kiara SM Ward S Kokwaro G Sasi P Marsh K Borrmann S Mackinnon M Nzila A
Malar J, (2009). 8:106

Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1.Mackintosh CL Christodoulou Z Mwangi TW Kortok M Pinches R Williams TN Marsh K Newbold CI
Malar J, (2008). 7:155

The decline in paediatric malaria admissions on the coast of Kenya.Okiro EA Hay SI Gikandi PW Sharif SK Noor AM Peshu N Marsh K Snow RW
Malar J, (2007). 6:151

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.Kinyanjui SM Conway DJ Lanar DE Marsh K
Malar J, (2007). 6:82

Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa.Ochong E Nzila A Kimani S Kokwaro G Mutabingwa T Watkins W Marsh K
Malar J, (2003). 2:46